John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$226M |
| 2 |
JPMorgan Chase
JPM
|
+$212M |
| 3 |
TSMC
TSM
|
+$204M |
| 4 |
Occidental Petroleum
OXY
|
+$194M |
| 5 |
Apple
AAPL
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$271M |
| 2 |
Microsoft
MSFT
|
+$267M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$255M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$226M |
| 5 |
Coca-Cola
KO
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.48% |
| 2 | Healthcare | 15.21% |
| 3 | Industrials | 10.23% |
| 4 | Consumer Discretionary | 10.15% |
| 5 | Financials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
PUT
VanEck Semiconductor ETF
SMH
$65.9B
| $297K | ﹤0.01% |
2,200
-1,400
| -39% | -$192K |
|
|
SNP
2202
DELISTED
CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES)
SNP
| $297K | ﹤0.01% |
+6,004
| New | +$301K |
|
|
ZEPP
2203
Zepp Health
ZEPP
$74.6M
| $296K | ﹤0.01% |
25,699
+3,427
| +15% | +$55.4K |
|
2204
Digimarc Corp
DMRC
$131M
| $295K | ﹤0.01% |
+11,183
| New | +$335K |
|
2205
Amtech Systems
ASYS
$249M
| $294K | ﹤0.01% |
29,240
-40,830
| -58% | -$390K |
|
2206
Fortuna Silver Mines
FSM
$3.68B
| $294K | ﹤0.01% |
77,100
-97,228
| -56% | -$368K |
|
2207
Stock Yards Bancorp
SYBT
$2.49B
| $293K | ﹤0.01% |
+5,538
| New | +$317K |
|
2208
Pulse Biosciences
PLSE
$3.49B
| $290K | ﹤0.01% |
+59,636
| New | +$488K |
|
2209
Johnson Outdoors
JOUT
$479M
| $287K | ﹤0.01% |
3,687
-12,017
| -77% | -$1.01M |
|
2210
Cardlytics
CDLX
$25.2M
| $286K | ﹤0.01% |
520
-9,885
| -95% | -$5.97M |
|
2211
Investar Holding Corp
ISTR
$417M
| $286K | ﹤0.01% |
14,988
-2,700
| -15% | -$52.3K |
|
2212
Cavco Industries
CVCO
$4.52B
| $285K | ﹤0.01% |
+1,182
| New | +$326K |
|
|
ONIT
2213
Onity Group
ONIT
$294M
| $285K | ﹤0.01% |
11,989
-12,589
| -51% | -$411K |
|
|
KBAL
2214
DELISTED
Kimball International
KBAL
| $285K | ﹤0.01% |
33,714
-45,716
| -58% | -$434K |
|
2215
Bassett Furniture
BSET
$164M
| $284K | ﹤0.01% |
+17,171
| New | +$292K |
|
2216
Relmada Therapeutics
RLMD
$490M
| $283K | ﹤0.01% |
+10,500
| New | +$217K |
|
|
ITI
2217
DELISTED
Iteris, Inc.
ITI
| $282K | ﹤0.01% |
94,639
+1,290
| +1% | +$4.47K |
|
2218
Darden Restaurants
DRI
$25B
| $278K | ﹤0.01% |
+2,091
| New | +$289K |
|
2219
Wabash National
WNC
$506M
| $278K | ﹤0.01% |
+18,746
| New | +$331K |
|
2220
Community Bank
CBU
$3.31B
| $277K | ﹤0.01% |
3,944
-5,672
| -59% | -$413K |
|
2221
Allient
ALNT
$1.58B
| $276K | ﹤0.01% |
9,248
-11,508
| -55% | -$403K |
|
|
AFIB
2222
DELISTED
Acutus Medical Inc
AFIB
| $276K | ﹤0.01% |
198,759
-40,251
| -17% | -$86.1K |
|
2223
Brilliant Earth
BRLT
$21.6M
| $275K | ﹤0.01% |
26,727
-102,501
| -79% | -$1.17M |
|
2224
Western New England Bancorp
WNEB
$276M
| $275K | ﹤0.01% |
30,715
-4,720
| -13% | -$42.8K |
|
|
MSP
2225
DELISTED
Datto Holding Corp.
MSP
| $275K | ﹤0.01% |
10,300
-97,057
| -90% | -$2.41M |
|
Similar funds
John Overdeck's Q1 2022 Portfolio in Review
As of Q1 2022, John Overdeck held 4,846 positions worth $33.9B, down 28% from $46.8B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
John Overdeck withdrew a net $11.3B in Q1 2022, closing 2,304 positions and reducing 976 holdings. Its most notable exit was Pfizer, an estimated $271M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, John Overdeck opened a new position in Cisco worth $223M.
- John Overdeck's largest Q1 2022 buy was Cisco: 4,001,362 shares worth $223M.
- John Overdeck added most to JPMorgan Chase in Q1 2022, an estimated $212M increase.
- John Overdeck's biggest Q1 2022 reduction was Coca-Cola, cutting an estimated $225M.
- John Overdeck fully exited Pfizer in Q1 2022, selling an estimated $271M.
- John Overdeck's ten largest holdings make up 7.2% of its $33.9B portfolio in Q1 2022.
- John Overdeck opened 656 new positions and closed 2,304 in Q1 2022.
- John Overdeck's portfolio value fell 28% quarter-over-quarter to $33.9B.
Based on Two Sigma Investments's 13F filing for Q1 2022, filed 16 May 2022.